These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3813005)

  • 21. Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis.
    Marshall JF; Apostolopoulos JJ; Brack CM; Howlett GJ
    Biochim Biophys Acta; 1990 Feb; 1042(3):271-9. PubMed ID: 2306478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification.
    Utermann G; Beisiegel U
    Eur J Biochem; 1979 Sep; 99(2):333-43. PubMed ID: 115688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein.
    Bearnot HR; Glickman RM; Weinberg L; Green PH; Tall AR
    J Clin Invest; 1982 Jan; 69(1):210-7. PubMed ID: 6798073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of apolipoprotein A-I in rat high density lipoprotein and in rat plasma by radioimmunoassay.
    Schonfeld G; Frick MS; Bailey AP
    J Lipid Res; 1976 Jan; 17(1):25-9. PubMed ID: 176289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational properties of human and rat apolipoprotein A-IV.
    Dvorin E; Mantulin WW; Rohde MF; Gotto AM; Pownall HJ; Sherrill BC
    J Lipid Res; 1985 Jan; 26(1):38-46. PubMed ID: 3973512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration in lipoprotein composition with intravenous compared to intragastric fat-free feeding in the rat.
    Ney DM; Lefevre M; Schneeman BO
    J Nutr; 1986 Nov; 116(11):2106-20. PubMed ID: 3098934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet.
    Lingenhel A; Eder C; Zwiauer K; Stangl H; Kronenberg F; Patsch W; Strobl W
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1509-13. PubMed ID: 15356672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
    Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
    Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay.
    Koren E; Puchois P; McConathy WJ; Fesmire JD; Alaupovic P
    Clin Chim Acta; 1985 Apr; 147(2):85-95. PubMed ID: 3921293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of human plasma apolipoprotein A-1: pretreatment of plasma with guanidine hydrochloride.
    Akazawa S; Ikeda Y; Kuriya N; Nakanishi T; Toyama K; Miyake S; Nagataki S
    Artery; 1985; 12(6):388-98. PubMed ID: 3931612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay of arginine-rich apolipoprotein of rat serum.
    Fainaru M; Havel RJ; Imaizumi K
    Biochim Biophys Acta; 1977 Jan; 490(1):144-55. PubMed ID: 189822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls.
    Ezeh B; Haiman M; Alber HF; Kunz B; Paulweber B; Lingenhel A; Kraft HG; Weidinger F; Pachinger O; Dieplinger H; Kronenberg F
    J Lipid Res; 2003 Aug; 44(8):1523-9. PubMed ID: 12777472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proapolipoprotein A-I conversion kinetics in vivo in human and in rat.
    Ghiselli G; Gotto AM; Tanenbaum S; Sherrill BC
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):874-8. PubMed ID: 3919384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of serum apolipoprotein patterns in rats during suckling and post-weaning periods.
    Imaizumi K; Lu YF; Sugano M
    Biochim Biophys Acta; 1987 Feb; 917(2):269-78. PubMed ID: 3099847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.